// App-Quantinova.ai

446 : Immunopeptidome changes mediated by a novel ERAP1 inhibitor leads to tumor growth inhibition

Researchers

Presenter

  • Peter Joyce

Principal Investigators

  • Lesley Young

  • Martin Quibell

  • Jason Shiers

  • Carmen Tong

  • Kristopher Clark

  • Edd James

  • Emma Reeves

  • Alihussein Remtulla

  • Henry Leonard

  • Camila de Almeida

  • Elisa Lori

  • Nicola Ternette

  • Fergus Poynton

  • Andrew Leishman

Medical Centers

  • Grey Wolf Therapeutics Ltd, Oxford, UK

  • Sygnature Discovery, Nottingham, UK

  • University of Southampton, Southampton, UK

  • Charles River Laboratories, Portishead, UK

  • Certara, Chester, UK

  • OCDEM, University of Oxford, Oxford, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved